According to the CDC, three patients in an Arizona pain management clinic who received contrast media injections from the same container during radiologic imaging were admitted to the hospital for ...

Clariscan is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging or MRI in brain (intracranial), spine and associated tissues in adult and pediatric ...

Gadoterate Meglumine Injection is a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues ...

Adverse reactions The most common adverse reactions (≥ 0.2%) associated with Clariscan in clinical trials were nausea, headache, injection site pain, injection site coldness and rash.

"IV contrast for CT is not associated with increased risk of acute kidney injury." ScienceDaily. ScienceDaily, 26 January 2017. <www.sciencedaily.com / releases / 2017 / 01 / 170126142848.htm>.

One common concern emergency medicine professionals face is the risk for acute kidney injury (AKI) secondary to the use of intravenous (IV) contrast for CT studies. Currently, emergency medicine ...

Merck says Keytruda injection on par with approved IV version in trial By Reuters November 19, 202411:21 AM PSTUpdated November 19, 2024 ...